Manns, M. P.
Article History
First Online: 30 April 2018
Interessenkonflikt
: M.P. Manns gibt folgenden Interessenkonflikt an: Fördergelder: AbbVie, Biotest, Boehringer Ingelheim, Bristol Myers Squibb, Eiger, Falk Pharma, Gilead, GlaxoSmithKline, Intercept, Janssen, Merck (MSD), Novartis, Roche; Beratung: AbbVie, Biotest, Boehringer Ingelheim, Bristol Myers Squibb, Eiger, Enyo Pharma, Falk Pharma, Gilead, GlaxoSmithKline, Intercept, Janssen, Medgenics, Merck (MSD), Novartis, Roche; Vorträge: AbbVie, Bristol Myers Squibb, Falk Pharma, Gilead, Janssen, Merck (MSD), Roche; Reisekostenunterstützung: AbbVie, Biotest, Boehringer Ingelheim, Bristol Myers Squibb, Falk Pharma, Gilead, GlaxoSmithKline, Janssen, Merck (MSD), Novartis, Roche; Monitoring Board/ Data Analysis: Falk Pharma